Skip to main content
Clinical Trials/NCT04106427
NCT04106427CompletedNot Applicable

Brain Stimulation And Group Therapy to Improve Gesture and Social Skills in Psychosis (BrAGG-SoS) - a Randomized, Placebo-controlled, Double-blind Trial of Transcranial Magnetic Stimulation and Group Therapy

University of Bern1 site in 1 country73 target enrollmentStarted: December 1, 2019Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
73
Locations
1
Primary Endpoint
change in gesture performance using the Test of Upper Limb Apraxia (TULIA)

Study Overview

Brief Summary

Randomized, double-blind, placebo-controlled clinical trial testing the effects of 10 sessions of continuous theta burst stimulation and the effects of 16 sessions of social cognitive remediation therapy on gesture performance and nonverbal communication skills in schizophrenia

Detailed Description

The study focuses on nonverbal communication skills in schizophrenia. The trial will test, whether the combination of noninvasive brain stimulation and group psychotherapy will improve gesture performance and thus nonverbal communication in schizophrenia

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

Masking Description

Assessments will be conducted by blind assessors. Participants will be blind to the type of psychotherapy and the type of rTMS administered

Eligibility Criteria

Ages
18 Years to 65 Years (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • •Right-handed subjects
  • •Ability and willingness to participate in the study
  • •Ability to provide written informed consent
  • •Informed Consent as documented by signature
  • •schizophrenia spectrum disorders according to Diagnostic and statistical manual version 5 (DSM-5)

Exclusion Criteria

  • •Substance abuse or dependence other than nicotine
  • •Past or current medical or neurological condition associated with impaired or aberrant movement, such as brain tumors, stroke, M. Parkinson, M. Huntington, dystonia, or severe head trauma with subsequent loss of consciousness.
  • •Epilepsy or other convulsions
  • •History of any hearing problems or ringing in the ears
  • •Standard exclusion criteria for cerebral magnetic resonance imaging scanning and transcranial magnetic stimulation (TMS); e.g. metal implants, claustrophobia
  • •Patients only: any transcranial magnetic stimulation (TMS) treatment in the past 3 months
  • •Patients only: any cognitive remediation therapy in the past 2 years
  • •Women who are pregnant or breast feeding,
  • •Intention to become pregnant during the course of the study,
  • •Female participants who are surgically sterilised / hysterectomised or post-menopausal for longer than 2 years are not considered as being of child bearing potential.
  • •Previous enrolment into the current study,
  • •Enrolment of the investigator, his/her family members, employees and other dependent persons

Arms & Interventions

cTBS plus SCRT

Experimental

10 daily sessions of continous theta burst (cTBS) on the right inferior parietal cortex for two weeks together with 16 sessions of social cognitive remediation therapy (SCRT) twice per week over an eight week period according to the manual

Intervention: continuous theta burst stimulation (cTBS) (Device)

cTBS plus SCRT

Experimental

10 daily sessions of continous theta burst (cTBS) on the right inferior parietal cortex for two weeks together with 16 sessions of social cognitive remediation therapy (SCRT) twice per week over an eight week period according to the manual

Intervention: social cognitive remediation therapy (SCRT) (Behavioral)

Placebo plus SCRT

Placebo Comparator

10 daily sessions of placebo continous theta burst (cTBS) on the right inferior parietal cortex for two weeks together with 16 sessions of social cognitive remediation therapy (SCRT) twice per week over an eight week period according to the manual

Intervention: placebo cTBS (Device)

Placebo plus SCRT

Placebo Comparator

10 daily sessions of placebo continous theta burst (cTBS) on the right inferior parietal cortex for two weeks together with 16 sessions of social cognitive remediation therapy (SCRT) twice per week over an eight week period according to the manual

Intervention: social cognitive remediation therapy (SCRT) (Behavioral)

Sham SCRT

Sham Comparator

16 sessions of sham social cognitive remediation therapy (SCRT) twice per week over an eight week period. Participants will engage in non-effective group activities

Intervention: Sham group therapy (Behavioral)

Outcomes

Primary Outcomes

change in gesture performance using the Test of Upper Limb Apraxia (TULIA)

Time Frame: baseline, week 2, week 8, week 32

Test of upper limb apraxia (TULIA), recorded on video and scored according to manual. contains 48 items (gestures performed on verbal or visual instruction), total score ranges 0-240; higher scores indicate better performance.

Secondary Outcomes

  • change in Social and occupational functioning (SOFAS)(baseline, week 2, week 8, week 32)
  • change in Self evaluation of negative symptoms (SNS)(baseline, week 2, week 8, week 32)
  • number of participants with treatment related adverse events as assessed with rating scale(week 2)
  • change in the profile of nonverbal sensitivity (PONS)(baseline, week 2, week 8, week 32)
  • change in functional capacity (UPSA brief)(baseline, week 2, week 8, week 32)
  • change in neural activity during gesture planning using functional magnetic resonance imaging (fMRI)(baseline, week 8)
  • change in Brief Negative Symptoms Scale (BNSS)(baseline, week 2, week 8, week 32)
  • change in the specific level of functioning assessment scale (SLOF)(baseline, week 2, week 8, week 32)

Investigators

Sponsor Class
Other
Responsible Party
Sponsor

Study Sites (1)

Loading locations...

Similar Trials